Expression of nm23-H1 in uveal melanoma

Melanoma Research

Volumn 17, Issue 5, 2007, Pages 284-290

  Bakalian, Silvin ^a   Marshall, Jean Claude ^a   Faingold, Dana ^a   Logan, Patrick ^a   Antecka, Emilia ^a   Burnier Jr , Miguel N ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Invasive ability; nm23 H1; Survival rate; Uveal melanoma

Indexed keywords

MESSENGER RNA; MONOCLONAL ANTIBODY; NUCLEOSIDE DIPHOSPHATE KINASE A; SMALL INTERFERING RNA;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE EXPRESSION; GENE SILENCING; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; KAPLAN MEIER METHOD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UVEA MELANOMA;

COLLAGEN; DRUG COMBINATIONS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; LAMININ; MELANOMA; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NM23 NUCLEOSIDE DIPHOSPHATE KINASES; PROTEOGLYCANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SKIN NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; UVEAL NEOPLASMS;

EID: 34648846089     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/CMR.0b013e3282eeea5a     Document Type: Article

References (25)

1. Egan KM, Seddon JM, Glynn RJ, Gragoudas ES, Albert DM. Epidemiologic aspects of uveal melanoma. Surv Ophthalmol 1988; 32:239-251.
2. Shields JA. Management of posterior uveal melanoma: past, present, future. Retina 2002; 22:139-142.
3. Singh AD, Topham A. Survival rates with uveal melanoma in the United States: 1973-1997. Ophthalmology 2003; 110:962-965.
4. Accuracy of diagnosis of choroidal melanomas in the Collaborative Ocular Melanoma Study. COMS report no. 1. Arch Ophthalmol 1990; 108: 1268-1273.
5. McLean IW. The biology of haematogenous metastasis in human uveal malignant melanoma. Virchows Arch A Pathol Anat Histopathol 1993; 422:433-437.
6. Eskelin S, Pyrhonen S, Summanen P, Hahka-Kemppinen M, Kivela T. Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment. Ophthalmology 2000; 107:1443-1449.
7. Steeg PS. Metastasis suppressors alter the signal transduction of cancer cells. Nat Rev Cancer 2003; 3:55-63.
8. Palmieri D, Horak CE, Lee JH, Halverson DO, Steeg PS. Translational approaches using metastasis suppressor genes. J Bioenerg Biomembr 2006; 38:151-161.
9. Steeg PS, Bevilacqua G, Kopper L, Thorgeirsson UP, Talmadge JE, Liotta LA, Sobel ME. Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 1988; 80:200-204.
10. Lacombe ML, Milon L, Munier A, Mehus JG, Lambeth DO. The human Nm23/nucleoside diphosphate kinases. J Bioenerg Biomembr 2000; 32:247-258.
11. Steeg PS, Ouatas T, Halverson D, Palmieri D, Salerno M. Metastasis suppressor genes: basic biology and potential clinical use. Clin Breast Cancer 2003; 4:51-62.
12. Yamaguchi A, Urano T, Fushida S, Furukawa K, Nishimura G, Yonemura Y, et al. Inverse association of nm23-H1 expression by colorectal cancer with liver metastasis. Br J Cancer 1993; 68:1020-1024.
13. Tokunaga Y, Urano T, Furukawa K, Kondo H, Kanematsu T, Shiku H. Reduced expression of nm23-H1, but not of nm23-H2, is concordant with the frequency of lymph-node metastasis of human breast cancer. Int J Cancer 1993; 55:66-71.
14. Marshall JC, Caissie AL, Callejo SA, Antecka E, Burnier MN Jr. Cell proliferation profile of five human uveal melanoma cell lines of different metastatic potential. Pathobiology 2004; 71:241-245.
15. Woodward JK, Elshaw SR, Murray AK, Nichols CE, Cross N, Laws D, et al. Stimulation and inhibition of uveal melanoma invasion by HGF, GRO, IL-1alpha and TGF-beta. Invest Ophthalmol Vis Sci 2002; 43: 3144-3152.
16. McLean IW, Foster WD, Zimmerman LE, Gamel JW. Modifications of Callender's classification of uveal melanoma at the Armed Forces Institute of Pathology. Am J Ophthalmol 1983; 96:502-509.
17. Lee CS, Clarke RA, Tran KT, Kearsley JH, Chou ST. nm23 Protein expression and p53 immunoreactivity in cutaneous fibrohistiocytic tumors. Pathology 1999; 31:123-126.
18. McDermott NC, Milburn C, Curran B, Kay EW, Barry Walsh C, Leader MB. Immunohistochemical expression of nm23 in primary invasive malignant melanoma is predictive of survival outcome. J Pathol 2000; 190:157-162.
19. Diener-West M, Reynolds SM, Agugliaro DJ, Caldwell R, Cumming K, Earle JD. Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26. Arch Ophthalmol 2005; 123:1639-1643.
20. Hartsough MT, Steeg PS. Nm23/nucleoside diphosphate kinase in human cancers. J Bioenerg Biomembr 2000; 32:301-308.
21. Ma D, Luyten GP, Luider TM, Jager MJ, Niederkorn JY. Association between NM23-H1 gene expression and metastasis of human uveal melanoma in an animal model. Invest Ophthalmol Vis Sci 1996; 37:2293-2301.
22. Greco IM, Calvisi G, Ventura L, Cerrito F. An immunohistochemical analysis of nm23 gene product expression in uveal melanoma. Melanoma Res 1997; 7:231-236.
23. Seregard S, Oskarsson M, Spangberg B. Differential expression of nm23 H-1 protein in conjunctival melanoma and potential precursor lesions. Exp Eye Res 1999; 69:671-676.
24. Bardak Y, Cekic O, Ayhan A, Gunalp I, Bulay O. nm23 Expression in choroidal melanoma. Ophthalmic Res 2000; 32:257-260.
25. Khan MH, Yasuda M, Higashino F, Haque S, Kohgo T, Nakamura M, Shindoh M. nm23-H1 Suppresses invasion of oral squamous cell carcinoma-derived cell lines without modifying matrix metalloproteinase-2 and matrix metalloproteinase-9 expression. Am J Pathol 2001; 158:1785-1791.